Karen Scappaticci

Director at AlphaVax - Durham, NC, US

Karen Scappaticci's Contact Details
HQ
800-658-2849
Location
Greater New York City Area
Company
AlphaVax
Karen Scappaticci's Company Details
AlphaVax logo, AlphaVax contact details

AlphaVax

Durham, NC, US • 100 - 249 Employees
BioTech/Drugs

The AlphaVax pipeline is targeting pandemic influenza and cytomegalovirus (CMV), as well as grant and collaborator-supported programs in HIV, prostate and breast cancer, and several biodefense vaccines. Clinical data from the first alphavaccine human trials have confirmed safety and immunological activity in man. These immune responses are characterized as robust and balanced antibody (B-cell) and cellular (T-cell) immune responses, confirming the promising data we have obtained in over a decade of intensive pre-clinical work with this vector platform.

alphavirus vaccine BioTech/Drugs Commercial Physical Research Biotechnology
Details about AlphaVax
Frequently Asked Questions about Karen Scappaticci
Karen Scappaticci currently works for AlphaVax.
Karen Scappaticci's role at AlphaVax is Director.
Karen Scappaticci's email address is ***@alphavax.com. To view Karen Scappaticci's full email address, please signup to ConnectPlex.
Karen Scappaticci works in the BioTech/Drugs industry.
Karen Scappaticci's colleagues at AlphaVax are Jon Smith, Anita Simkins, Betsy Jordan, Danny Franks, Peter Young, Brian Chidziva, Andrew Graham and others.
Karen Scappaticci's phone number is 800-658-2849
See more information about Karen Scappaticci